Regression estimates and incidence rate ratios from GLMER for number of papers (top) and coauthors (bottom). by William C. Barley (8915282)

Study characteristics and estimates of <i>Giardia</i> infection prevalence associations. Statistically significant values are bolded. by Kareem Hatam-Nahavandi (7384790)

Subjects:

Success rate of depth estimation for different signal-to-noise ratios. by Du Siqi (20721422)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

Estimated parametric coefficients of GAM Models with interaction for Incidence, Lethality and Mortality rates due to Covid-19 in pregnant and postpartum women. by Marcela de Andrade Pereira Silva (12877870)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The effect of CWI on (A) creatinine levels, (B) estimated glomerular filtration rate (eGFR) and correlations between these parameters before (C) and after (D) CWI in young healthy... by Aneta Teległów (9570190)

<i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation. by Siyun Lee (17087351)

Estimated detected and non-detected colorectal cancer rates and their clinical stages based on colorectal cancer screening in Minamisoma City in 2011. by Hiroaki Saito (24514)

Subjects:

Modelled seroprevalence estimates (coloured regions) compared with real data (black). by Keith Fraser (1868587)

Subjects:

Global and national estimates of deaths due to <i>Klebsiella pneumoniae</i>-associated lower respiratory infections in 1990 and 2021. by Juanjuan Li (399633)

Subjects:

Summary of Pooled Estimates and Heterogeneity for Key Variables. by Yohannis Derbew Molla (16471771)

Subjects:

Mortality rates per lifecycle stage [28]. by Albertus Constantijn Sloof (20405090)

“…Implementing rapid vaccination after detecting the virus in ten individuals and achieving 40% coverage could reduce infection rates by 82%, preventing 139,805 cases. Scenario and sensitivity analyses confirm that even with lower vaccination coverage rates, significant benefits are observed: at 10% coverage, the number of infections drops to 115,231, and at 20% coverage, it further reduces to 76,031. …”

Most significant muscle activation values. by María Benito-de-Pedro (22057468)

Subjects:

Global and national estimates of disability-adjusted life years (DALYs) due to <i>Klebsiella pneumoniae</i>-associated lower respiratory infections in 1990 and 2021. by Juanjuan Li (399633)

Subjects:

Estimation results of spatial Durbin panel data model. by Yuanzhi Guo (16624797)

Subjects:

Significant repeated measurements sEMG outcomes. by María Benito-de-Pedro (22057468)

Subjects:

Significant single measurement sEMG outcomes. by María Benito-de-Pedro (22057468)

Subjects:

Estimation results of spatial Durbin panel data model by regions. by Yuanzhi Guo (16624797)

Subjects:

Estimation of transmission rates of influenza A and B in the United States using actual data. by Shuanglin Jing (11886368)

Subjects: